Skip to main content

Natera, Inc.

corporate_fare Company Profile

Natera, Inc.

NTRA·NASDAQ·Industrial Applications And Services·CIK 0001604821

Natera, Inc. is a diagnostics company that utilizes proprietary molecular and bioinformatics technology to manage diseases globally. The company's cell-free DNA (cfDNA) technology integrates novel molecular assays, which accurately measure numerous informative regions across the genome from samples as small as a single cell, with statistical algorithms that incorporate scientific data to identify genetic variations for a wide range of serious conditions with high accuracy and coverage. Natera aims to integrate personalized genetic testing and diagnostics into standard medical care to protect health and enable earlier, more targeted interventions. The company applies its technology across three primary healthcare areas: oncology, women's health, and organ health. Since 2009, Natera has introduced a comprehensive suite of products to enhance patient care outcomes in these fields. In oncology, Natera commercializes personalized blood-based DNA tests to optimize therapy decisions from diagnosis through survivorship. For women's health, the company develops and commercializes non- or minimally-invasive tests for needs ranging from prenatal testing to hereditary cancer screening. In organ health, Natera provides tests to assess kidney, heart, and lung transplant rejection, alongside genetic testing for chronic kidney disease. Natera operates with a direct sales force in the United States and a global network of over 100 laboratory and distribution partners, including several large international laboratories. As of December 31, 2025, the company had over 350 peer-reviewed publications and over 650 issued or pending patents. Natera's revenues were $2,306.1 million in 2025, compared to $1,696.9 million in 2024 and $1,082.6 million in 2023.

Natera, Inc. (NASDAQ:NTRA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 29 items for NTRA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for NTRA spans 10-Q, 8-K.

Recent high-impact activity:

  • Natera Slides 15% as Wider-Than-Expected Q3 Loss Overshadows Revenue Beat and Raised Outlook
  • Natera Q3 Revenue Jumps 34% to $794M; Net Loss Narrows to $59.9M
  • Natera Promotes 15-Year Veteran Moshkevich to CEO as Chapman Steps Down
  • Natera Beats on 34% Revenue Growth, Lifts 2026 Guidance by $140M
  • Medicare Covers Signatera MRD Test in Liver Cancer, Opening New Surveillance Market

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.31B
Net Income
-$208.16M
Diluted EPS
-$1.52
Op. Cash Flow
$215.3M
Free Cash Flow
$109.11M
Operating Income
-$309.91M
Cash & Equivalents
$1.08B
Total Debt
$80.32M
Debt / Equity
0.05×
Net Margin
-9.0%
Shares Outstanding
139.69M sh
Source: 10-K · filed 2026-02-27 · accession 0001104659-26-020881

Short Interest & Short Volume

4.15 days to cover

FINRA reported short interest of 6,072,554 shares in NTRA as of the October 30, 2026 settlement, a 3.8% increase from the prior period — about 4.2 days to cover at its recent average daily volume. On November 20, 2026, 45.7% of NTRA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)6,072,554 shares as of October 30, 2026
Change vs prior period▲ 3.8%
Days to cover4.15 at avg daily volume of 1,461,627
Daily short volume (FINRA facilities)45.7% of 669,681 shares on November 20, 2026
5-day average short volume38.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for NTRA, detected from its recent SEC filings · based on capital-structure filings through 2026-11-11.

1 shelf registration

Resale Registration of Merger Shares · Small Deal, No Proceeds to Natera

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with N →
$274.16 +0.28% today
52-week range · as of 2026-11-05 $181 – $437.41
Market cap
$39.64B
Volume
1.4M (0.7× avg)
3-mo avg 2M
Live data · 2026-11-21 23:07 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NTRA - Latest Insights

NTRA
Nov 06, 2026, 11:25 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $316.02
Real-time Price: $274.16 info
Change: -$41.86 (-13%) info
Market Cap: $39.644B info
NTRA
Nov 05, 2026, 4:49 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $293.97
Real-time Price: $274.16 info
Change: -$19.81 (-7%) info
Market Cap: $39.644B info
NTRA
Nov 05, 2026, 4:06 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $366.75
Real-time Price: $274.16 info
Change: -$92.59 (-25%) info
Market Cap: $39.644B info
NTRA
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $363.76
Real-time Price: $274.16 info
Change: -$89.60 (-25%) info
Market Cap: $39.644B info
NTRA
Nov 03, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $380.77
Real-time Price: $274.16 info
Change: -$106.61 (-28%) info
Market Cap: $39.644B info
NTRA
Oct 09, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $391.54
Real-time Price: $274.16 info
Change: -$117.38 (-30%) info
Market Cap: $39.644B info
NTRA
Oct 06, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $429.97
Real-time Price: $274.16 info
Change: -$155.81 (-36%) info
Market Cap: $39.644B info
NTRA
Oct 05, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $409.00
Real-time Price: $274.16 info
Change: -$134.84 (-33%) info
Market Cap: $39.644B info
NTRA
Sep 22, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $370.05
Real-time Price: $274.16 info
Change: -$95.89 (-26%) info
Market Cap: $39.644B info
NTRA
Sep 18, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $367.00
Real-time Price: $274.16 info
Change: -$92.84 (-25%) info
Market Cap: $39.644B info
NTRA
Sep 01, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $323.30
Real-time Price: $274.16 info
Change: -$49.14 (-15%) info
Market Cap: $39.644B info
NTRA
Aug 06, 2026, 8:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $275.00
Real-time Price: $274.16 info
Change: -$0.840 (-0.31%) info
Market Cap: $39.644B info
NTRA
Aug 06, 2026, 4:35 PM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $308.22
Real-time Price: $274.16 info
Change: -$34.06 (-11%) info
Market Cap: $39.644B info
NTRA
Aug 05, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $270.72
Real-time Price: $274.16 info
Change: +$3.44 (+1%) info
Market Cap: $39.644B info
NTRA
Jul 22, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $262.09
Real-time Price: $274.16 info
Change: +$12.07 (+5%) info
Market Cap: $39.644B info
NTRA
Jul 16, 2026, 6:35 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $270.65
Real-time Price: $274.16 info
Change: +$3.51 (+1%) info
Market Cap: $39.644B info
NTRA
Jun 24, 2026, 3:01 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $235.06
Real-time Price: $274.16 info
Change: +$39.10 (+17%) info
Market Cap: $39.644B info
NTRA
Jun 16, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $219.56
Real-time Price: $274.16 info
Change: +$54.60 (+25%) info
Market Cap: $39.644B info
NTRA
May 20, 2026, 7:09 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $197.59
Real-time Price: $274.16 info
Change: +$76.57 (+39%) info
Market Cap: $39.644B info
NTRA
May 19, 2026, 6:09 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $197.75
Real-time Price: $274.16 info
Change: +$76.41 (+39%) info
Market Cap: $39.644B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets